208 related articles for article (PubMed ID: 8516656)
1. Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride.
Inoue M; Sekiguchi T; Harasawa S; Miwa T; Miyoshi A
Scand J Gastroenterol Suppl; 1993; 195():36-8; discussion 38-9. PubMed ID: 8516656
[TBL] [Abstract][Full Text] [Related]
2. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
Eberl T; Barnert J; Dumitrascu DL; Fischer J; Wienbeck M
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
[TBL] [Abstract][Full Text] [Related]
3. Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices.
Verhaeghe J; Jaecques N; Rombouts J; Spaepen W; Cardon E; Lebrun F; Meurant JP
Scand J Gastroenterol Suppl; 1993; 195():25-34; discussion 34-5. PubMed ID: 8516655
[TBL] [Abstract][Full Text] [Related]
4. Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial.
Chung JM
Scand J Gastroenterol Suppl; 1993; 195():11-4. PubMed ID: 8516653
[TBL] [Abstract][Full Text] [Related]
5. [Interdigestive migrating complex (IMC) and effect of cisapride in patients with non-ulcer dyspepsia (NUD)].
Sekiguchi T; Horikoshi T; Nishioka T; Kusano M; Matsuzaki T; Kawamura O; Miyazaki M; Kikuchi K
J Smooth Muscle Res; 1991 Jun; 27(3):131-7. PubMed ID: 1840866
[TBL] [Abstract][Full Text] [Related]
6. A German drug-monitoring study in general practice patients receiving cisapride for functional dyspepsia.
Liehr H; Schmidt R
Scand J Gastroenterol Suppl; 1993; 195():54-8; discussion 58-9. PubMed ID: 8516660
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting short- and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients.
Heyse PM; Rambaldo R; Hazelhoff B
Scand J Gastroenterol Suppl; 1993; 195():15-23; discussion 23-4. PubMed ID: 8516654
[TBL] [Abstract][Full Text] [Related]
8. Risk factors, co-medication, and concomitant diseases: their influence on the outcome of therapy with cisapride.
Fehr HF
Scand J Gastroenterol Suppl; 1993; 195():40-5; discussion 45-6. PubMed ID: 8516657
[TBL] [Abstract][Full Text] [Related]
9. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life.
Abell TL; Cutts TF; Cooper T
Scand J Gastroenterol Suppl; 1993; 195():60-3; discussion 63-4. PubMed ID: 8516661
[TBL] [Abstract][Full Text] [Related]
10. Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia.
Cutts TF; Abell TL; Karas JG; Kuns J
Dig Dis Sci; 1996 Jul; 41(7):1369-78. PubMed ID: 8689913
[TBL] [Abstract][Full Text] [Related]
11. A double-blind fluoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia.
Degryse H; De Schepper A; Verlinden M
Scand J Gastroenterol Suppl; 1993; 195():1-4. PubMed ID: 8516652
[TBL] [Abstract][Full Text] [Related]
12. Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.
Hveem K; Hausken T; Svebak S; Berstad A
Scand J Gastroenterol; 1996 May; 31(5):452-7. PubMed ID: 8734341
[TBL] [Abstract][Full Text] [Related]
13. Gastric emptying in patients with non ulcer dyspepsia (dysmotility type).
Mittal BR; Dhiman RK; Maini A; Sewatkar AB; Das BK
Trop Gastroenterol; 1997; 18(2):67-9. PubMed ID: 9323919
[TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
15. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
Rezende-Filho J; Di Lorenzo C; Dooley CP; Valenzuela JE
Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cisapride therapy in functional dyspepsia.
Kellow JE; Cowan H; Shuter B; Riley JW; Lunzer MR; Eckstein RP; Höschl R; Lam SK
Aliment Pharmacol Ther; 1995 Apr; 9(2):153-60. PubMed ID: 7605855
[TBL] [Abstract][Full Text] [Related]
18. Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients.
Testoni PA; Bagnolo F; Fanti L; Passaretti S; Tittobello A
Gut; 1990 Mar; 31(3):286-90. PubMed ID: 2323591
[TBL] [Abstract][Full Text] [Related]
19. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
Wood SF; Penney SC; Cochran KM
Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659
[TBL] [Abstract][Full Text] [Related]
20. [Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis].
Scalon P; Di Mario F; Meggiato T; Basso D; Battaglia G; Vianello F; Fogar P; Del Favero G
Minerva Gastroenterol Dietol; 1992; 38(2):101-4. PubMed ID: 1391144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
